New York, February 26, 2018:

    High Potency API and HPAPI Market 2018

    The High Potency API /HPAPI Market is expected to exceed more than US$ 24.00 Billion by 2022 at a CAGR of 8.5% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets onHigh Potency API /HPAPI Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Novartis International AG (Switzerland), Sanofi (France), Pfizer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Mylan Inc. (U.S.), AbbVie Inc. (U.S.), and Merck & Co., Inc. (U.S.).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You Can Find Full Report @: https://www.marketresearchengine.com/high-potency-api-hpapi-market

    The major driving factors of High Potency API /HPAPI Market are as follows:

    •   Growth in the oncology drugs showcase,
    •   Growing interest for counter acting agent medicate conjugates,
    •   Increasing center of pharmaceutical organizations around HPAPIs,
    •   Progressions in HPAPI advancements.

    The restraining factors of High Potency API /HPAPI Market are as follows:

    • Stringent administrative necessities
    • Requirement of extensive ventures

    The High Potency API /HPAPI Market is segmented on the lines of its type of manufacture, type of synthesis, type, therapeutic application and regional. Based on type of manufacture segmentation it covers captive manufacturers, merchant manufacturers. Based on type of synthesis segmentation it covers synthetic hpapis market, biotech hpapis market, by type. Based on type segmentation it covers Innovative HPAPIs, Generic HPAPIs. Based on therapeutic application segmentation it covers oncology, hormonal disorders, glaucoma, other therapeutic applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction). The High Potency API /HPAPI Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:

    1) An overview of the global market for High Potency API /HPAPI Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
    3) Identifications of new market opportunities and targeted promotional plans for High Potency API /HPAPI Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    REPORT SCOPE:

    The scope of the report includes a detailed study of global and regional markets onHigh Potency API /HPAPI Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Novartis International AG (Switzerland), Sanofi (France), Pfizer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Mylan Inc. (U.S.), AbbVie Inc. (U.S.), and Merck & Co., Inc. (U.S.).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The High Potency API and HPAPI Market has been segmented as below :(Accordingly)

    By Type of Manufacturer Analysis:

    • Captive Manufacturers
    • Merchant Manufacturers
      • Merchant Manufacturers, by Type
        • Innovative
        • Generic
      • Merchant Manufacturers, by Type of Synthesis
        • Synthetic
        • Biotech

    By Type of Synthesis Analysis:

    • Synthetic HPAPIs Market
      • Synthetic HPAPIs Market, by Type
        • Innovative Synthetic HPAPIs
        • Generic Synthetic HPAPIs
        • Biotech HPAPIs Market
    • Biotech HPAPIs Market
      • Innovative Biotech HPAPIs
      • Biosimilars

    By Type Analysis:

    • Innovative HPAPIs
    • Generic HPAPIs

    By Therapeutic Application Analysis:

    • Oncology
    • Hormonal Disorders
    • Glaucoma
    • Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

    By Regional Analysis

    North America
    Europe
    Asia-Pacific
    Rest of the World

     

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    4.1 High Potency Active Pharmaceutical Ingredients Market Overview
    4.2 High Potency Active Pharmaceutical Ingredients Market, By Type
    4.3 High Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis
    4.4 High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Area
    4.5 High Potency Active Pharmaceutical Ingredients Market: Geographic Snapshot

    5 Market Overview

    6 High Potency Active Pharmaceutical Ingredients Classification and Overview

    7 High Potency Active Pharmaceutical Ingredients Market, By Type

    8 High Potency Active Pharmaceutical Ingredients Market, By Type of Synthesis

    9 High Potency Active Pharmaceutical Ingredients Market, By Type of Manufacturer

    10 High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application

    11 High Potency Active Pharmaceutical Ingredients Market, By Region

    12 Competitive Landscape

    13 Company Profiles

    13.1 Introduction

    13.2 Pfizer, Inc.

    13.3 Novartis International AG

    13.4 Sanofi

    13.5 F. Hoffmann-La Roche Ltd.

    13.6 Bristol-Myers Squibb

    13.7 Boehringer Ingelheim

    13.8 Teva Pharmaceutical Industries Ltd.

    13.9 ELI Lilly and Company

    13.10 Merck & Co., Inc.

    13.11 Abbvie Inc.

    13.12 Mylan N.V.

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

     

    Source: http://www.financeswire.com/high-potency-api-and-hpapi-market-2018-industry-analysis-growth-and-forecast-to-2022